Pharmaceutical wholesale & export — request a bulk quote
Aceclofenac & Paracetamol
Aceclosyn-P 100 mg & 325 mg tablet combines aceclofenac and paracetamol for symptomatic relief of pain and inflammation in acute musculoskeletal and soft-tissue conditions.
In stock
Aceclosyn-P is a combination analgesic tablet containing aceclofenac and paracetamol formulated for the symptomatic management of pain and inflammation. The product pairs a non-steroidal anti-inflammatory agent with a widely used analgesic/antipyretic to address both inflammatory pain and general pain relief. It is supplied as film-coated tablets in a pack size of 1 x 20 tablets suitable for wholesale and institutional purchase.
The active components work through complementary mechanisms. Aceclofenac is an NSAID that exerts anti-inflammatory and analgesic effects primarily by inhibiting prostaglandin synthesis at sites of tissue injury. Paracetamol (acetaminophen) provides analgesic and antipyretic activity, believed to act centrally to reduce pain perception and fever. Together, these ingredients can offer more comprehensive symptomatic control than either agent alone for appropriate indications.
Aceclosyn-P tablets are intended for short-term symptomatic treatment of mild to moderate pain associated with musculoskeletal disorders, soft-tissue injuries, dental pain, and other situations where combined analgesic and anti-inflammatory therapy is considered appropriate. This product information is provided for healthcare procurement and product selection; specific indications, duration of use, contraindications, interactions, and safety information are described in the prescribing information and should be reviewed prior to use.
Use of Aceclosyn-P should follow local regulatory guidance and the recommendations of a qualified healthcare professional. The medicine is not suitable for patients with known hypersensitivity to aceclofenac, paracetamol, other NSAIDs, or any excipients in the formulation. Caution is advised in populations with relevant medical conditions or who are taking concomitant medications that may interact with NSAIDs or paracetamol. For dosing, administration, full safety profile and patient selection, refer to the approved prescribing information and consult a clinician.
For wholesale, distribution or export enquiries, please contact our sales team with required volumes, destination and regulatory documentation needs. We can provide product specifications, batch information and standard commercial documentation upon request.
NSAIDs can increase the risk of cardiovascular thrombotic events, myocardial infarction and stroke, particularly with prolonged use or in patients with cardiovascular disease. NSAIDs may cause serious gastrointestinal adverse events including bleeding, ulceration and perforation. Paracetamol overdose can cause severe liver injury. Use this product under the guidance of a qualified healthcare professional.
Store in a cool, dry place away from direct sunlight and out of reach of children. Follow storage directions on the pack label.
Aceclosyn-P is a tablet formulation combining aceclofenac (an NSAID) and paracetamol (an analgesic/antipyretic). The combination is used to provide analgesic and anti-inflammatory effects in conditions where both agents are appropriate. Consult product labeling for full details.
Regulatory status can vary by market. The administrative listing indicates non-prescription, but local regulations and institutional policies determine availability. Confirm with local regulatory authorities or a qualified healthcare professional before distribution or sale.
Key concerns include the risks associated with NSAIDs (cardiovascular and gastrointestinal events), potential hepatic toxicity from paracetamol in overdose, contraindications for patients with NSAID hypersensitivity, and the need to review concomitant medications for interactions. Ensure recipients have access to prescribing information and patient counseling materials.
Minimum order quantities, packaging configurations and pricing are managed by the exporter and distributor agreements. Documentation on pack size provided: 1 x 20 tablets. For specific MOQ and commercial terms, please request a formal quotation and trade documentation from the supplier.
Yes. Standard commercial and regulatory documents such as certificates of analysis, batch release information and product dossiers are typically available on request. Provide details of the intended market so the exporter can supply appropriate documentation and compliance information.
This tablet formulation does not require cold chain transport. Shipments should protect product from heat, moisture and sunlight. Specific shipping instructions, packaging standards and storage requirements will be provided by the exporter; always follow the pack label and contractual shipping terms.
You may also need
Pain Killer
tapentadol
50 MG · 1X10 Tablet
By Signature

Pain Killer
Pregabalin
75 MG · 1X14 Capsule
By Pfizer Ltd